BMI Healthcare, the UK's largest hospital chain by number of sites, has announced the completion of a previously-announced deal that sees Hospital Topco Limited, a company majority owned by PE firm Centerbridge and effective landlord of most of BMI's hospital properties, become majority owner of BMI's operating company. What now?
US real-estate investor Heitman has entered the Dutch elderly care market with the acquisition of De Leyhoeve, a high-end assisted living facility for the elderly. We speak to a Dutch market expert about its business model, which takes a luxurious approach to assisted living.
Australian private equity AMP Capital has bought UK specialist care provider Care Management Group (CMG). We speak to AMP's CEO, and a market expert who gives us his take on the deal and what it means for the market.
After a long career at radiotherapy supplier Varian where he ended as Vice President, Global Market Development, Michael has set up his own consultancy to advise governments, international agencies and the private sector on the development of radiation therapy services in general and the best business models. HBI asks him where the opportunities are and what they look like.
London-listed EMEA healthcare group NMC Health says the final agreement on its joint venture in Saudi Arabia with state-owned investor Hassana will be signed in Q1 2019, which seems contrary to earlier filings saying it would be completed in the current quarter. We talk to CEO Prasanth Manghat about the deal there, the payor climate in neighbouring UAE and the group's strategy more broadly.
German dialysis, hospital, rehab and pharma group Fresenius has seen its share price fall 15% after it cut its medium-term guidance, owing to lower profit expectations at its dialysis and hospital businesses.
Insurers and big occupational healthcare providers are sceptical about a new generation of lifestyle genetic testing linked to apps which are designed to enable individuals to achieve higher levels of wellness. But they are starting to deploy more specific tests that diagnose rare diseases. We talk to major operators and insurers about how they see the genetic test market.
According to a report by real-estate investor Octopus Healthcare, both current and new investors in UK elderly care will be allocating increasing resources to the sector, despite the market experiencing significant financial challenges. We speak to the company's CEO, Benjamin Davis, about why UK elderly care remains a hotspot for investment.
Hospital operators listed in Germany, South Africa, Australia and the UK have been outperformed by their indices over the past three years, and NMC, the main exception on the FTSE 100, recently took a kicking because of critical note from Jefferies. What does that say for the sector which was always supposed to be recession-proof?
A month ago we wrote that pan-Asian hospital group IHH Healthcare might be looking to exit its Turkish subsidiary, Acibadem. Over the past week, it revealed a loss in Q3 because of the Lira's fall and also announced a new single-largest shareholder. One source suggests it might be looking to sell before March's local elections in Turkey.
We hear the big Russian groups are moving away from IVF as the government funds the treatment at aggressively low tariffs, allowing public hospitals to encroach on market which has historically been the bedrock of the big private sector players. The IVF market in Russia stood at just under 30bn Rubles (€400m) in 2016 growing at […]
London-listed international healthcare group NMC Health has taken a 7% kicking to its share price. The drop comes after investment bank Jefferies' latest note, its most critical yet. We put those critiques to the company which dismissed suggestions it has changed direction, saying it is "not looking to extend our core business to developed markets."